Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds SRNEQ.
No tracked institution reports a position in SRNEQ as of their last filing.
No one on the platform has traded SRNEQ yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Beat consensus in 1 of the last 7 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2023-08-11 | $-0.15 | $-0.17 | -13.3% |
| 2023-05-15 | $-0.16 | $-0.26 | -62.5% |
| 2023-03-16 | $-0.19 | $-0.46 | -142.1% |
| 2022-11-08 | $-0.25 | $-0.20 | +20.0% |
| 2022-08-15 | $-0.25 | $-0.54 | -116.0% |
| 2022-03-11 | $-0.29 | $-0.47 | -62.1% |
| 2021-11-05 | $-0.23 | $-0.40 | -73.9% |
| $13M |
| — |
| EMMLFOKYO Pharma Limited | $0.01 | +0.00% | $23M | — |
| NOXOFNoxopharm Limited | $0.04 | +0.00% | $15M | — |
Source: Financial Modeling Prep · peers by sector/industry